Quote | Ainos Inc (OTCMKTS:AIMD)
Last: | $3.02 |
---|---|
Change Percent: | 313.7% |
Open: | $3.56 |
Close: | $0.73 |
High: | $3.56 |
Low: | $2.9 |
Volume: | 83,003 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Ainos Inc (OTCMKTS:AIMD)
Study to evaluate clinical effectiveness of low-dose oral interferons in treating chronic gingivostomatitis in cats, building upon VELDONA's history in animal health since 1985 Clinical trials are expected to run for approximately ten months from May 24, 2024. SAN DIEGO, CA / ACCESSWIRE...
2024-05-14 12:43:13 ET More on Ainos Financial information for Ainos Read the full article on Seeking Alpha For further details see: Ainos reports Q1 results
Message Board Posts | Ainos Inc (OTCMKTS:AIMD)
Subject | By | Source | When |
---|---|---|---|
Huge gains today on 51 million shares traded. | subslover | investorshub | 03/15/2023 2:42:12 AM |
Here ya go | subslover | investorshub | 03/14/2023 11:32:07 AM |
News? | Awl416 | investorshub | 03/14/2023 11:05:15 AM |
THANKS AGAIN, T-B-T-9460!! | Invest-in-America | investorshub | 10/01/2022 3:30:26 PM |
$AIMD Strong bottom bounce here..and check out that | TommyBoyTrader9460 | investorshub | 10/01/2022 3:20:27 PM |
News, Short Squeeze, Breakout and More Instantly...
Ainos Inc Company Name:
AIMD Stock Symbol:
OTCMKTS Market:
Study to evaluate clinical effectiveness of low-dose oral interferons in treating chronic gingivostomatitis in cats, building upon VELDONA's history in animal health since 1985 Clinical trials are expected to run for approximately ten months from May 24, 2024. SAN DIEGO, CA / ACCESSWIRE...
Strategic focus on VELDONA and AI-powered point-of-care testing continues during 2024 US$9M growth capital secured in May strengthens financial position for executing growth strategy SAN DIEGO, CA / ACCESSWIRE / May 13, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...